Literature DB >> 2015329

Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

J Rosen1, G S Zubenko.   

Abstract

Prospective psychiatric evaluations were performed as part of a longitudinal study of 32 demented patients who met criteria for the histopathological diagnosis of Alzheimer's disease at the time of death. Psychosis and major depressive disorder emerged in 15 (47%) and 7 (22%) patients, respectively, none of whom had a history of either behavioral disorder prior to the onset of dementia. The prevalence of psychosis increased with increasing dementia severity, was associated with more rapid cognitive decline, and once present was often persistent. In this regard, the emergence of psychosis in the context of Alzheimer's disease appears to be a poor prognostic sign. In contrast to its relationship to cognitive impairment, psychosis was not associated with an increased mortality rate.

Entities:  

Mesh:

Year:  1991        PMID: 2015329     DOI: 10.1016/0006-3223(91)91284-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

1.  Clinical characteristics of community-dwelling black Alzheimer's disease patients.

Authors:  D G Harwood; W W Barker; R L Ownby; R Duara
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

Review 2.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 3.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

4.  ["The living image sign" in a patient with Alzheimer's disease].

Authors:  P Demers; H Létourneau; A Robillard; E St-André
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

Review 5.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Factors associated with psychotic symptoms in Alzheimer's disease.

Authors:  N Hirono; E Mori; M Yasuda; Y Ikejiri; T Imamura; T Shimomura; M Ikeda; M Hashimoto; H Yamashita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

7.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

8.  Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.

Authors:  Raffaele Nardone; Yvonne Höller; Aljosha Thomschewski; Alexander Baden Kunz; Piergiorgio Lochner; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-28       Impact factor: 3.575

9.  Hallucinations, delusions, and cognitive decline in Alzheimer's disease.

Authors:  R S Wilson; D W Gilley; D A Bennett; L A Beckett; D A Evans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

Review 10.  Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?

Authors:  Subramoniam Madhusoodanan; Payal Shah; Ronald Brenner; Sanjay Gupta
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.